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Abstract
The availability of electronic health care records is unlocking the potential for novel studies on understanding and modeling
disease co-morbidities based on both phenotypic and genetic data. Moreover, the insurgence of increasingly reliable
phenotypic data can aid further studies on investigating the potential genetic links among diseases. The goal is to create a
feedback loop where computational tools guide and facilitate research, leading to improved biological knowledge and
clinical standards, which in turn should generate better data. We build and analyze disease interaction networks based on
data collected from previous genetic association studies and patient medical histories, spanning over 12 years, acquired
from a regional hospital. By exploring both individual and combined interactions among these two levels of disease data,
we provide novel insight into the interplay between genetics and clinical realities. Our results show a marked difference
between the well defined structure of genetic relationships and the chaotic co-morbidity network, but also highlight clear
interdependencies. We demonstrate the power of these dependencies by proposing a novel multi-relational link prediction
method, showing that disease co-morbidity can enhance our currently limited knowledge of genetic association.
Furthermore, our methods for integrated networks of diverse data are widely applicable and can provide novel advances for
many problems in systems biology and personalized medicine.
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Introduction
Many diseases do not occur in isolation. Diseases with similar
genetic, environmental, and lifestyle risk factors may be co-morbid
in patients, or the disease products themselves may be risk factors
for additional conditions. Also, many serious chronic diseases, such
as cancer and diabetes, are complex diseases influenced by a
combination of environment and epistasis between many genes
[1–3]. In this way, diseases may share many distinct types of
relationships with varying levels of impact for important problems
such as patient risk or drug efficacy. Thus, a singular view of
dependencies among diseases is not sufficient. Rather, disease
mechanisms form a complex system. The underlying goal is to
combine all available information and develop the most complete
models of interaction between these many factors, simultaneously
using information widely applicable and patient specific.
Schadt [3] suggests that diseases can be seen as emergent from a
complex network of underlying molecular activity influenced by
genesandenvironment.Indeed,complexnetworksareanaturalway
of representing any data with complicated dependency relationships.
Unfortunately, most network studies and standard tools are
insufficient for the task, limited to treating all relationship types
equally or separate analysis of each type. Both of these approaches
represent a loss of information. In this study, we use patient medical
histories (phenotype data) and previously discovered disease-gene
associations to construct, analyze, and compare disease-disease
networks. We then take a novel approach to studying interplay
between patients, diseases, and genes by merging the heterogeneous
data into a multi-relational network and analyzing the structure of
interaction between shared genes and clinical co-mordibidity.
Finally, we demonstrate how the multi-relational structure can be
applied to enhance the link prediction task of determining good
targets for further gene association research.
Both gene-based [4] and patient-based [5] disease-disease
networks, constructed similarly to ours, have been previously
studied. These separate studies explore different questions, while
our approach is to compare and combine the networks and take
the composite view. In [6], Park et al. begin exploring relationships
between the network links, showing that genetic association is
correlated with co-morbidity and thus justifying integrated study.
However, they do not take advantage of the network structure,
and there are still many questions to be addressed for useful
inference between the networks. Also, as our networks will show,
diseases show far more co-morbidities than genetic links to other
diseases, so direct inference based on shared genetic association
only applies to a limited subset of co-morbidities. Park et al.
acknowledge that many disease pairs share genes but are not co-
morbid, and we will further show that there are far more disease
co-morbidities without significant gene overlap. Our explicit
integration of the networks facilitates inference based on a
neighborhood of interactions, providing a richer pool of data
than pairwise correlation.
Many other studies have explored integrating diverse evidence
to answer biological questions, using various types of data [7–11].
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22670We have already mentioned some of the limitations of simple
correlation studies, particularly with respect to inference tasks.
Another approach which has been used is classification using
diverse evidence, such as the work on predicting gene-disease
associations performed by Radivojac et al. in [9]. Classification has
proven to be a good tool for many tasks, but we claim that
network-based inference has certain differences that may be
advantageous for biological data. Most currently available data,
particularly on the molecular level, is incomplete, biased, and
noisy, which corresponds to a great deal of missing or unreliable
data. Classification methods must impute values for missing data
to create positive and negative profiles for each decision class,
which can hurt performance [12]. Most complex networks
methods, including the link prediction method we will introduce,
apply naturally to whatever partial information is known.
There have been a limited number of recent studies on link
prediction in multi-relational networks [13–15]. Latent feature
models have been extended for potentially overlapping multi-
relational link prediction. In [14], each relation is separately
predicted based on a global set of latent features by generating a
separate set of weights for each feature. In [15], a single set of
prediction weights is scaled by a different factor for each relation.
Unlike these approaches, the main focus of our work is directly
capturing the correlation structure between relationship patterns.
Results and Discussion
Network Descriptions
We constructed a phenotypic disease network (PDN) [5] from
real patient data in which nodes are diseases and edges indicate co-
morbidity of the diseases. Co-morbidity can be broadly defined as
co-occurrence in the same patients significantly more than chance.
We included edges between disease pairs for which the co-
occurrence (joint probability) is significantly greater than the
random expectation based on population prevalence of the diseases
(product of marginal probabilities). Statistical significance is
determined by a one-tailed two proportion z-test with 95%
confidence. Additionally, diseases are required to have a minimum
co-occurrence in 2 patients to avoid noise from lone rare events.
Diseaseswith nosignificantrelationshipsareomitted.Foradditional
details about the data, see Materials and Methods. Our phenotypic
disease network consists of 437 unique diseases nodes and 40,579
co-morbidity relationships, creating a very dense network.
We also constructed a genetic disease network (GDN) [4] from
gene-disease associations compiled from previous studies. Nodes are
unique diseases, which are connected when the diseases share a
significant number of genetic associations. Similar to the PDN,
disease pairs have an edge if they share significantly more gene
associations than randomly expected based on the generality of the
diseases. We approximated the generality with the marginal
probability of the disease being associated with a random gene
from the dataset. Again, significance was decided by a two
proportion z-test with 95% confidence. The genetic disease network
has 399 nodes connected with 7817 significant genetic links.
For the methods in this paper, we primarily utilized unweighted
networks. However, we found a weighting scheme to be useful for
some observations. We weighted the edges using a mutual
information metric which quantifies how much greater the edge
relationship is with respect to chance. For details, see Materials and
Methods.
Diseases considered for inclusion in the networks were limited to
those which appeared in both datasets; that is, diseases which are
associated with at least one gene and occur in at least one patient.
However, we do not necessarily require significant relationships in
both. The overlap of the network is 399 nodes; all diseases in the
GDN also had at least one significant co-morbidity. However, the
PDN contains 38 additional diseases that have significant co-
morbidities, have some known gene associations, but are not
sufficiently genetically similar to any other diseases.
In both networks, the diseases are classified by Disease Ontology
(DO) codes, which have a hierarchical structure. The structure is
arranged such that a code may be a subset of other codes at many
levels of generality, creating long chains of ‘is-a’ relationships. For
example, Toxic pneumonitis is a Pneumonia is a Non-neoplastic lung
disorder. Obviously, the is-a relationship is fundamentally different
from other edges in the networks and should be treated as such.
These links are essential to the structure of the network, so they
were included but not weighted.
Network Analysis and Comparison
For each network, we calculated the degree distribution and
spectrum of clustering coefficients, which are shown in Figure 1.
Figure 1. Global network properties. (A) Degree distributions and (B) clustering spectrums of the phenotypic (PDN) and genetic (GDN) disease
networks. The PDN has higher average degree and clustering coefficient due to very high edge density. Interestingly, the degree distribution of the
GDN generally decreasing while the PDN is more uniform, indicating that many diseases are co-morbid with a large number of other diseases, often
with few or no underlying shared genes.
doi:10.1371/journal.pone.0022670.g001
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generally have more co-morbidities than genetic associations.
Thus, it is unsurprising that the phenotypic network has higher
average degree and clustering coefficient. More interesting,
however, is the remarkable difference in degree distribution.
While the degree distribution in the genetic network is generally a
decreasing function, the phenotypic degree distribution is more
uniform. Neither of these networks have a power-law degree
distribution [16]. Since these networks mostly contain the same
nodes, this difference indicates that many conditions are highly co-
morbid despite few or no shared genes. For example, migraines do
not have significant genetic link to any other disease, but are co-
morbid with more than 200 conditions. Note that a lack of genetic
edges does not mean the conditions are not genetic, but rather that
their known genetic profile is not similar to other diseases.
Both networks were computationally clustered using Walktrap,
a hierarchical clustering tool for networks based on the intuition
that random walks are often trapped within dense network regions
corresponding to clusters. Algorithm details are provided in [17];
we use the implementation provided by the authors with the
default parameters. The reported clusters correspond to the
partition with the highest modularity [18]. The clustered networks
are provided in Figure 2, along with limited descriptions of the
clusters. Due to the high density, the visual representations are
limited to strongest 10% of edges in each network according to the
mutual information weights. All of the nodes remain present. The
reduced networks are for visual clarity only; the clusters and
associated descriptions correspond to the full network. We describe
the content of each cluster by finding the DO term(s) that are most
pure or complete within the cluster. Each node has a DO code
which is further associated with a hierarchy of more general terms.
For each DO term and cluster, we define purity as the percentage
of all cluster members which are contained by the term, and
completeness as the percent of all nodes contained by the term that
also belong to the cluster. A detailed example of these calculations
can be found in Materials and Methods. Intuitively, the purity
indicates the homogeneity of the cluster, while completeness
measures the uniqueness relative to other clusters. Dynamic, fully
labeled representations of the networks are available at http://
www.nd.edu/dial/plosone/diseasenetworks/in Cytoscape format,
an open source tool for visualizing and analyzing networks [19].
The PDN was partitioned into 10 clusters, four of which are of
acceptable quality due to size, purity, and completeness. By
acceptable, we simply mean that the cluster is non-trivial and has a
reasonably specific universal theme. These clusters can be roughly
classified as neuromuscular and neuro-degenerative disease, sensation
disorders, malignant neoplasms, and female reproductive system disorders.
Four of the remaining clusters are tiny groups of related
conditions, consisting almost entirely of is-a edges. The final two
clusters are enormous ‘‘catch-all’’ clusters of mixed conditions,
accounting for 56.98% of all disease nodes in combination. One of
these large clusters contains the famously complex relationships
between heart disease, diabetes, strokes, obesity, and many other chronic
diseases believed to be lifestyle influenced. The other large cluster
contains most of the congenital deformities. Both of these clusters
additionally contain many other disease categories which were not
easily separable, forming a chaotic picture of intra-connections
across disease families and organ systems.
The GDN was separated into 11 clusters, with seven high
quality clusters. Again, neoplasms and nervous system disease form
fairly pure clusters. Genetic clusters also form for heart disease,
endocrine diseases, and diseases of the hematopoietic system. Similar to the
PDN, there are 3 tiny clusters, but only one mixed cluster of
moderate size, accounting for about 19.55% of the nodes. Overall,
clusters in the GDN are more specific and separated than the
PDN, although in both cases there are many conditions which do
not form distinct modules.
Network Integration
The PDN and GDN provide insight into the way genes
associate with diseases and the way diseases occur in patients, but
little information about the interplay between the two mecha-
nisms. The structures suggest that the two networks express
different information for understanding disease mechanisms,
which is not unexpected. There are multiple possible reasons,
both biological and artificial, which we can speculate are behind
these differences. Two diseases being associated with the same
gene might not have a practical effect, especially if the diseases are
associated with different loci, alleles, or expression levels. This
corresponds to a connection in the GDN and none in the PDN. In
the other direction, some diseases may be co-morbid only because
they are influenced by the same environmental conditions. Finally,
both networks are likely to have collection biases, although we
expect that the PDN is more complete. However, these differences
do not preclude the possibility of important patterns and
dependencies between the structures. We combined the individual
network information into a multi-relational disease network
(MRDN) and probabilistically analyzed local structures to draw
more specific conclusions about how genetic influences relate to
disease co-morbidity.
We previously mentioned that the patient-based and gene-based
networks were constructed from the same pool of diseases. While
some diseases have significant relationships only in the PDN, the
majority of the node sets overlap. Thus, the networks contain
many of same disease nodes but with a different pattern of
connections and weights. This allows them to be easily overlaid
and represented as a single multi-relational network with multiple
edge types. The edge type can be thought of as a nominal edge
attribute. If both a phenotypic and a genetic edge is present
between two diseases, it was treated as a single edge of type ‘both’.
The multi-relational structure also allows the is-a relationship to be
explicitly treated as a unique edge type. This fundamental disease
relationship supersedes any other correlations. Thus, the MRDN
has four possible edge types: (G)enetic, (P)henotypic, (B)oth genetic
and phenotypic, and (I)s-a. The clusters from the original networks
can be retained as separate node attributes.
The integrated MRDN is shown in Figure 3. The edge colors
represent the relationship type. The two-tone nodes indicate
original cluster membership in the GDN (inner circle) and PDN
(outer circle). Areas matching the white background color indicate
that the node was omitted from one of the networks. Groups of
nodes with a matching two-tone pattern are overlaps between
clusters found in the separate networks. It is visually apparent that
substantial overlap between the cluster results is common.
However, the clusters never fully overlap, nor are they contained
within each other. In general, phenotypic influence tends to
extend far beyond the bounds of genetic similarity. Consistent with
Park et al.’ s result that sharing genes is correlated with co-
morbidity [6], we observe that 72% of genetic edges underlie a
phenotypic edge. In Figure 4, we plot the genetic mutual
information versus the phenotypic mutual information for the
4465 disease pairs which have both relationships. While the
positive correlation between the values is highly significant
(Pearson correlation of 0.473, probability of random observation
p~0 according to a Monte Carlo permutation test of 1 million
permutations), it is a weak-to-moderate correlation in the general
sense, i.e. the strongest genetic relationships do not necessarily
translate to high co-morbidity, and vice versa. More details on the
Multi-Relational Gene and Phenotype Networks
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22670Figure 2. The Phenotypic and Genetic Disease Networks. (A) The phenotypic disease network (PDN) is constructed based on clinical history of
700,00 patients. Each node represents a unique disease, and two nodes are connected if the diseases co-morbid significantly more than randomly
expected according to population prevalence. (B) The genetic disease network (GDN) is constructed on the same disease nodes, but edges instead
indicate that the disease pair shares a significant number of gene associations. In both networks, black edges indicate hierarchically related diseases
(is-a relationships). For each network, the accompanying table displays the most relevant Disease Ontology codes associated with each cluster. Purity
corresponds to the percent of member nodes which are accurately described by the DO term, and completeness indicates the percentage of
descendants of the DO term which belong to the cluster. For a detailed definition, see Materials and Methods. It is clear that the PDN and GDN are
structurally different. Nonetheless, both networks form some easily defined clusters but also have some dense regions containing diverse DO terms.
doi:10.1371/journal.pone.0022670.g002
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Section.
Despite visually different structures, there are definite depen-
dencies between genetic association and co-morbidity, but pair-
wise correlations are weak indicators on their own. Nonetheless,
even weak evidence can be very valuable for inference tasks,
particularly in combination with complementary evidence, which
is our approach. Furthermore, we suspect that the PDN can be
very valuable for inference in regions of the GDN which have
been sparsely studied, perhaps due to rarity or low morbidity.
Multi-relational Local Structure
Construction and manual observation of the multi-relational
network has already confirmed significant interplay between the
genetic and phenotypic networks. However, there are still many
questions about the basic rules and probabilities that govern these
influences, particularly in terms of strength. In addition to
furthering biological understanding of disease mechanisms,
understanding the probabilistic properties of the network structure
will be instrumental to locating additional genetic associations or
recognizing the role of genetics in poorly understood co-
morbidities.
We approach these global questions through the local
substructures, which can provide manageable and interpretable
insights into the global structure [20]. For this study, we counted
the occurrence of each unique 3-node structure, traditionally
called triad census [21,22] and more recently defined as counting
3-node graphlets [23]. Triad census has been widely used in social
network analysis, often for evaluating local structure hypotheses
such as transitivity [24]. The triad census trivially extends to multi-
relational networks; the only difference is the number of unique
structures. While a traditional directed network yields 16 possible
structures, our network has 30 unique connected triad patterns of
the four edge types. Of course, the hypothesis space becomes
increasingly complex with each additional relation. For this work,
our use of triad counts is more similar to the context of recent work
Figure 3. The Multi-Relational Disease Network. This network is created by overlaying the phenotypic (PDN) and genetic (GDN) networks,
which contain the same disease nodes. Blue edges indicate phenotypic links, red edges are genetic, green edges are both genetic and phenotypic,
and black edge are is-a relationships. The two-tone nodes indicate original cluster membership in the GDN (inner circle) and PDN (outer circle).
Regions where multiple nodes share the same color pattern correspond to groups of diseases which cluster together in both the PDN and the GDN.
These overlaps are common and in some cases quite large, such as the teal-and-green cluster containing the heart diseases. Still, none of the overlaps
fully contain a PDN or GDN cluster. The overlapping regions are listed in the accompanying table, along with the most relevant Disease Ontology
codes associated with the cluster.
doi:10.1371/journal.pone.0022670.g003
Figure 4. Genetic vs. phenotypic mutual information. Each data
point represents a disease pair which is linked in both the PDN and the
GDN. The plot illustrates the correlation between the mutual
information edges weights in each respective network. There is some
upward trend but the effect is far from linear. In aggregate, the values
have a Pearson correlation of .473, a weak-to-moderate positive
correlation.
doi:10.1371/journal.pone.0022670.g004
Multi-Relational Gene and Phenotype Networks
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thoroughly characterize the local structure [25]. Instead of
hypothesizing about which structures are important, we wish to
probabilistically weight all relationship patterns. The triad census
provides the probability of each structure, which further translates
to the probability that a partial triad is closed by each edge type. A
pictorial example is shown in Figure 5, and the probabilities found
in the real network can be seen in supplementary Table S1.
Multi-Relational Link Prediction
One of the great challenges for studying biological networks and
systems biology in general is the incompleteness and noise of the
data. In any large scale molecular context, especially considering
phenomena such as epistasis, experimentally exhausting all
combinations is not a viable option. Even experimental studies,
especially high-throughput methods, may be inconsistent or can
result in high false positive rates, thus requiring many trials or
diverse evidence to be reliable. Computational approaches such as
disease-gene prioritization are essential for targeting future
experiments, directing time and money towards the most likely
successes.
In complex networks, finding missing associations is the link
prediction problem, which can be broadly generalized as follows:
Given two nodes a and b that are not connected by an edge,
predict whether the edge actually does exist, or in the case of
dynamic interactions, will form in the near future. Usually, this
prediction is in the form of a score for each disease pair. The
scores are then ranked to determine the nodes pairs that are
relatively most likely to have an edge. Many link prediction
methods exist for networks; a survey of these methods can be
found in [26,27]. For this work, we focus on unsupervised
topological models.
However, most traditional link prediction methods have no
direct applicability to multi-relational networks other than treating
all edges equally, which can be detrimental to their performance
for many reasons. Different link types contain different informa-
tion by nature, and various combinations introduce different
amounts of evidence to the link prediction task. This is particularly
troublesome when the link types have very different frequency or
distribution, which is clearly the case in our multi-relational
disease network. In a sufficiently complicated system, some edge
types may be irrelevant or redundant with respect to certain
prediction tasks. Even if these barriers could be overcome, treating
all edges equally provides no information about the type of link
being predicted.
We propose a novel multi-relational link prediction (MRLP)
method which addresses all of these issues to predict the location
and type of new edges. The most important component of our
MRLP method is an appropriate weighting scheme for different
edge type combinations. In Multi-relational Local Structure,w e
explained how a triad census can be used to place a probability
on local substructures, which conveniently translates to a non-
arbitrary, data-justified weighting scheme. To account for
frequency disparity, the probabilistic weights are normalized by
the marginal probabilities of the edge types involved. Implemen-
tation details of our MRLP method and related traditional link
predictors can be found in Materials and Methods. Ours is a general
algorithm for multi-relational networks, which can also be trivially
extended to multiple node types.
We applied our probabilistically weighted MRLP to the multi-
relational disease network. For this application, we only generated
prediction scores for genetic links, since ‘is-a’ relationships are
known and we assume that the patient data completely represents
significant co-morbidities. We compared our performance to
traditional neighborhood-based link prediction methods as applied
to the genetic disease network (GDN). The algorithms used are
Common Neighbors, Jaccard coefficient, and the Adamic/Adar
measure (details in Materials and Methods). These methods provide a
baseline for how well the genetic links in our network can be
predicted without the benefit of multi-relational analysis. For all
experiments, we use 10-fold cross validation, holding out 10% of
the genetic edges for each run. The comparative performance is
shown by the receiver operating characteristic (ROC) curves and
precision-recall curve [28] in Figure 6. The MRLP outperforms
the traditional methods with respect to AUROC. The precision-
recall curve, which is potentially less biased by the extreme
imbalance between actual links versus all possible pairs, shows that
MRLP performs particularly well on the top 50 rankings, but is
not optimal for all decision boundaries, as one would expect. The
drop in precision as recall increases is expected, as it is
accompanied by an increase in false positives. When predicting
possible genetic links for further investigation, it is also important
to have fewer false positives, and thus the operating range might
be constrained to top-50 or top-100 rankings (precision at 50 or at
100, for instance). The MRLP also reaches 100% recall with
higher precision than the other methods, which we hypothesize is
due to an improved ability to distinguish between edges with very
low genetic evidence. These results indicate that phenotypic
information can help improve the prediction of genetic links
between diseases, even though less than 12% of the phenotypic
relationships coincide with an underlying genetic association.
We then applied the MRLP to a more difficult problem: a
disease with no known genetic associations, only a phenotypic
profile. Such a disease is disconnected in the GDN, and thus
cannot be predicted by the baseline algorithms applied to the
GDN as in previous experiment. The link predictions can be made
based on the PDN, but phenotypic evidence alone is weak. The
multi-relational approach provides a connection while allowing
the genetic associations of the other diseases in the network to still
play a role. Experimentally, we simulated this scenario by holding
Figure 5. Finding edge probabilities given partial structures.
This toy example demonstrates how to calculate the probability of a
specific edge type closing an open triad pattern, based on the triad
counts for the full network. This calculation corresponds the Equation 3.
The numbers in this example do not represent the real network. The
table of actual edge probabilities for the MRDN can be found in Table
S1.
doi:10.1371/journal.pone.0022670.g005
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using the MRLP to predict the correct locations of the removed
associations. Figure 7 shows the AUROC achieved for each
disease using the MRLP versus Adamic/Adar applied to
phenotypes only. Similar trends hold for MRLP versus the other
benchmark algorithms, slightly shifted leftward due to lower
average performance. The strong majority of diseases fall above
the diagonal, indicating that the multi-relational approach
improved the predictions for that disease. The genetic associations
were most easily predicted using phenotypic relationships for
alopecia, hypothyroidism, and complications of diabetes mellitus. The most
poorly predicted were schizophrenia, polymyositis, and frontotemporal
dementia.
Materials and Methods
Ethics Statement
The IRB at the University of Notre Dame, deemed the research
to be Exempt Under Category 4 (Research involving the collection
or study of existing data, documents, records, pathological
specimens, or diagnostic specimens, if these sources are publicly
available or if the information is recorded by the investigator in
such a manner that subjects cannot be identified, directly or
through identifiers linked to the subjects.).
The assurance number at Notre Dame is FWA00002462
expiration 09/23/2013 and IRB NUMBER is 00000329.
The exempt document is filed in records, and is dated 18th
March, 2009.
Data
We determined genes shared between diseases based on known
disease-gene associations extracted from OMIM, Swiss-Prot, and
HPRD. The diseases are classified by Disease Ontology (DO)
codes and the gene names are based on the HUGO Gene
Nomenclature. The Disease Ontology project is intended to
develop a controlled medical vocabulary to unify diverse medical
languages and ontologies such as UMLS, ICD, and SNOMED. It
is implemented as a directed acyclic graph indicating the
hierarchical structure of the disease terms.
Disease co-morbidity was calculated from real patient medical
histories collected from a group of 77 physicians within a regional
health system. This includes data for the last 12 years, from 1997
to 2009, with a total of 5.5 million visits for approximately 700,000
patients. Each data record is a single visit represented by an
anonymized patient ID and a primary diagnosis code, as defined
by the International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM). For consistency with the first
dataset, the ICD-9-CM codes have been converted to Disease
Ontology codes based on mappings provided within the DO
coding. The mapping is many to many, so a single ICD-9-CM
Figure 6. Link prediction performance. (A) Receiver operating curves (ROC) and (B) precision-recall curves for the multi-relational link predictor
(MRLP) and three traditional neighborhood-based link prediction methods: common neighbors, Jaccard coefficient, and the Adamic/Adar measure.
MRLP is the best method with respect to area under the receiver operating curve (AUROC). The precision-recall curve, which is less biased, shows that
MRLP is most accurate with the highest ranked predictions, but is not always optimal for lower prediction thresholds.
doi:10.1371/journal.pone.0022670.g006
Figure 7. Link predictor performance by individual disease.
Area under the receiver operating curve (AUROC) comparison of link
predictor performance for each unique disease. The experiments were
hold-one-out, where all genetic associations of the testing disease were
removed. The x axis shows the performance of Adamic/Adar on the
phenotypic data only, and the y axis is the performance using the MRLP
on the multi-relational network. Each point which falls above the
diagonal indicates that multi-relational evidence improved link
prediction performance for the corresponding disease.
doi:10.1371/journal.pone.0022670.g007
Multi-Relational Gene and Phenotype Networks
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apply to multiple ICD-9-CM codes as well.
Mutual Information Weighting
The mutual information weight w(d1,d2) between two diseases
d1 and d2 is defined as
w(d1,d2)~log
pd 1,d2 ðÞ
pd 1 ðÞ pd 2 ðÞ
  
ð1Þ
where the numerator is the observed co-occurrence (joint
probability) and the denominator is the random expectation of
co-occurrence (product of marginal probabilities). Co-occurrence
refers to the number of shared patients in the PDN, or the number
of shared genes in the GDN. This weighting scheme is used to
avoid bias based on disease prevalence, which is necessary since
previous work with the data [29] has shown that a few common
diseases tend to dominate other correlations.
Permutation Test
In order to determine if genetic mutual information and
phenotypic mutual information are significantly correlated for the
disease pairs in our networks, we used a Monte Carlo permutation
test. Each permutation was determined by randomly pairing each
genetic mutual information value with a phenotypic value using a
Fisher-Yates shuffle of each value set, respectively. We generated 1
million permutations, each with a corresponding Pearson correla-
tion value. The correlation values were within the range
½{0:0702,0:0699  with a mean value of 1e{5. The observed
Pearson correlation in our networks was 0.473, which falls well
outside the range generated from the permutations, which
corresponds to probability p~0 of random observation. We
concluded with highconfidencethat geneticand phenotypic mutual
information of the disease pairs is significantly positively correlated.
Cluster Purity and Completeness
As mentioned in Network Analysis and Comparison, we calculate the
purity and completeness of each network cluster with respect to
each DO term associated with the cluster members. We defined
purity as the percent of all cluster members which belong to a given
term and completeness as the percent of all nodes belonging to the
term that also belong to the cluster.
We now provide a detailed example of this calculation for a cluster
ofdisease terms{coccidiosis,malaria,arthropoddiseases,helmintiasis,parasitic
intestinal diseases}, which corresponds to the five blue nodes on the
upper right side of Figure 2A. These are all children of the DO term
infectious diseases, so the purity with respect to that term is
5
5
~1.
However, these are only 5 of the 21 infectious diseases inthe network, so
the completeness is
5
21
~0:238. Similarly, 4 of the 5 terms are parasitic
diseases (purity:
4
5
~0:8) and only one other parasitic disease is
included elsewhere in the network (completeness:
4
5
~0:8).
Purity and completeness can be determined for all cluster-DO
term pairs. The terms provided in Figure 2 are those that best
describe each cluster. While the determination of the best terms
was subjective, most clusters had clear winners. Otherwise, the
clusters have been marked as ‘‘mixed’’.
Link Prediction Algorithm
Our multi-relational link prediction (MRLP) approach works as
follows. Nodes a and b form a partial triad with each common
neighbor, and each partial triad provides a probabilistic weight
based on the triad census. We can then add the weights. Prediction
scores are found individually for each link type of interest.
Formally, the prediction score for edge type x between nodes a
and b is
scorex(a,b)~
X
n[DNa
T
NbD
wn ð2Þ
where
wn~
P type a,b ðÞ ~xDtype a,n ðÞ ,type b,n ðÞ ðÞ
P type a,n ðÞ ðÞ P type b,n ðÞ ðÞ
ð3Þ
As mentioned earlier, the denominator of the weight term is a
normalization factor to account for the frequency disparity
between edge types.
We further extend this equation to include the inverse frequency
principle, since it has been shown to increase performance in many
cases. The integration is direct except that the degree is counted only
withrespecttotherelevant node types.The predictionscore becomes
scorex a,b ðÞ ~
X
n[jNa
T
Nbj
wn
1
log
degreetype(a,n)n type a,n ðÞ ~type b,n ðÞ
degreetype(a,n)nzdegreetype(b,n)n type a,n ðÞ =type b,n ðÞ
(
ð4Þ
where degreex(n) is defined as the number of edges of n with edge
type x.
In supplementary Text S1, we describe additional approaches
using hierarchical clustering information as prior weighting for the
MRLP, which did not prove to be beneficial.
Benchmark Methods. We considered the neighborhood-
based topological methods, which are better suited to our networks
and make for a strong benchmark to the proposed MRLP. In this
case, topological refers to methods that rely only on the structure
of the network to draw conclusions.
Common neighbors is the simplest method, where the link
prediction score for the node pair a and b is
score(a,b)~DNa
\
NbD ð5Þ
where Nx is the set of all nodes connecting to node x (the
neighbors of x). Another well-known common neighbor method is
the Jaccard coefficient, where
score(a,b)~
DNa
T
NbD
DNa
S
NbD
ð6Þ
A third variation which usually improves performance significantly
is the Adamic/Adar measure [30], which weights the impact of
neighbor nodes inversely with respect to their total number of
connections. Specifically,
score(a,b)~
X
n[DNa
T
NbD
1
log degree n ðÞ ðÞ
ð7Þ
This inverse frequency approach is based on the principle that
rare relationships are more specific and have more impact on
similarity, which is justified in our network (recall the clustering
spectrum, Figure 1) and many other real world scenarios.
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